|
Press Releases |
|
![](/images/company/BioMedX_logo.jpg) |
|
Tuesday, May 28, 2024 |
|
BioMed X Institute and Boehringer Ingelheim Successfully Complete Schizophrenia Research Project |
German independent research institute BioMed X announces the successful completion of its second neuroscience project in partnership with Boehringer Ingelheim in the field of psychiatric disorders. The data resulting from this project have been acquired by Boehringer Ingelheim, where this research will be continued, potentially paving the way for novel therapies. more info >> |
|
Thursday, May 16, 2024 |
|
New XSeed Labs Research Team Starts Activity in the U.S. in Collaboration With Boehringer Ingelheim |
XSeed Labs - a collaboration between BioMed X and Boehringer Ingelheim, announces the start of its first research team on the Boehringer Ingelheim campus in Ridgefield, Connecticut. more info >> |
|
Tuesday, April 30, 2024 |
|
New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg |
BioMed X, a German biomedical research institute, announces the start of a new research project in partnership with Merck at its site in Heidelberg, Germany. The main objective of the project is to develop novel immunotherapeutic strategies to overcome the immunosuppressive microenvironment of solid tumors. more info >> |
|
Tuesday, February 6, 2024 |
|
New T-FINDER Platform Provides Deep Insights Into T Cell Responses Against Novel Cancer Vaccine |
more info >> |
|
Friday, December 22, 2023 |
|
BioMed X 研究所與小野藥品公司(Ono Pharmaceutical)在癌症研究領域啟動新的合作 |
more info >> |
|
BioMed X 研究所与小野药品公司(Ono Pharmaceutical)在癌症研究领域启动新的合作 |
more info >> |
|
BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research |
more info >> |
|
Tuesday, November 7, 2023 |
|
BioMed X Launches a New Call for Application in Autoimmune Disease Research |
more info >> |
|
Wednesday, November 1, 2023 |
|
BioMed X and AbbVie Start New Research Project in the USA |
more info >> |
|
Thursday, June 29, 2023 |
|
BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development |
BioMed X, a German independent research institute, announces the start of its first research project in collaboration with Sanofi: "Next Generation Virtual Patient Engine for Clinical Translation of Drug Candidates" (VPE). more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Lexaria Preparing For Strategic Growth
Jul 16, 2024 21:20 HKT/SGT
|
|
|
'Alamein Festival' Launches Exciting Second Edition for 2024
Jul 16, 2024 21:00 HKT/SGT
|
|
|
China Medical System (867.HK) Reincluded in S&P Global Sustainability Yearbook (China Edition) and Maintained MSCI ESG "AA" Rating
Jul 16, 2024 21:00: JST
|
|
|
China Medical System (867.HK) Reincluded in S&P Global Sustainability Yearbook (China Edition) and Maintained MSCI ESG "AA" Rating
Jul 16, 2024 20:00 HKT/SGT
|
|
|
How Artificial Intelligence Can Help Give Your Business a Boost
Jul 16, 2024 19:30 HKT/SGT
|
|
|
U.S. Polo Assn. Proudly Partners with the 2024 Outsourcing Inc. Royal Charity Polo Cup
Jul 16, 2024 19:00 HKT/SGT
|
|
|
Neste and Mitsubishi Corporation agree on strategic partnership to develop supply chains for renewable chemicals and plastics
Jul 16, 2024 18:36 JST
|
|
|
NEC technology reliably measures sea levels from a greater distance
Jul 16, 2024 17:45 JST
|
|
|
全球发展数字经济直播访谈会正式举办 外方来华参会高级别代表走进东方甄选直播间
Jul 16, 2024 15:08 HKT/SGT
|
|
|
巨星傳奇(6683.HK)解禁後首個交易日 收盤報10.4港元 升幅達2.97%
Jul 16, 2024 15:04 HKT/SGT
|
|
|
巨星传奇(6683.HK)解禁后首个交易日: 收盘报10.4港元 升幅达2.97%
Jul 16, 2024 14:58 HKT/SGT
|
|
|
全球發展數字經濟直播訪談會正式舉辦 外方來華參會高級別代表走進東方甄選直播間
Jul 16, 2024 14:25 HKT/SGT
|
|
|
Fujitsu and Cohere launch strategic partnership and joint development to provide generative AI for enterprises
Jul 16, 2024 15:13 JST
|
|
|
Komisi Penerbangan Malaysia Memilih TransNusa Sebagai Salah Satu Dari Dua Maskapai Asing Untuk Meluncurkan Penerbangan Dari Bandara Subang
Jul 16, 2024 14:00 HKT/SGT
|
|
|
エーザイ、ホスラブコナゾールのアジア・オセアニアにおけるライセンス契約を佐藤製薬と締結
Jul 16, 2024 13:00: JST
|
|
|
|
More News >> |
|
|
|
|
|